Jeffrey Cerio serves as the Senior Vice President, General Counsel, and Corporate Secretary at KORRO BIO INC, a pioneering biotechnology firm focused on developing novel genetic medicines. With a robust legal background spanning over two decades, Cerio has become an invaluable asset to KORRO BIO INC, steering the company through the complex landscape of biotechnology law and corporate governance. His expertise in intellectual property, regulatory compliance, and strategic transactions has been instrumental in advancing KORRO BIO INC's mission to bring innovative therapies to patients. Prior to joining KORRO BIO INC, Cerio held significant legal roles at several high-profile organizations within the life sciences and pharmaceutical sectors. Notably, he served as General Counsel at a leading gene therapy company, where he played a pivotal role in navigating the company through multiple successful clinical trials and regulatory milestones. Cerio's career also includes a stint at a top-tier law firm, where he honed his skills in corporate law, advising clients on mergers and acquisitions, licensing agreements, and other critical business transactions. His comprehensive understanding of the legal intricacies in the biotech industry, combined with his strategic foresight, has earned him a reputation as a thought leader and trusted advisor. In his current role at KORRO BIO INC, Cerio is responsible for overseeing all legal affairs, ensuring compliance with industry regulations, and safeguarding the company's intellectual property portfolio. He works closely with the executive team to develop and execute corporate strategies that align with KORRO BIO INC's long-term goals. Under his guidance, the company has successfully navigated the challenges of a rapidly evolving biotech landscape, securing key partnerships and advancing its pipeline of genetic medicines. Cerio's dedication to excellence and his ability to provide sound legal counsel have been crucial in positioning KORRO BIO INC as a leader in the field of genetic medicine.